相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group
Satrajit Roychoudhury et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2023)
Nonproportional Hazards-An Evaluation of the MaxCombo Test in Cancer Clinical Trials
Yuan-Li Shen et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2023)
Reconsidering the Direction of Coronary Revascularization Trials
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)
Survival analysis: Part I - analysis of time-to-event(vol 76, pg 83, 2023)
Junyong In et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2023)
Which test for crossing survival curves? A user's guideline
Ina Dormuth et al.
BMC MEDICAL RESEARCH METHODOLOGY (2022)
Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model
Peter C. Austin et al.
STATISTICS IN MEDICINE (2022)
Myocardial Infarction in the ISCHEMIA Trial Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons
Bernard R. Chaitman et al.
CIRCULATION (2021)
Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association
Andrew D. Althouse et al.
CIRCULATION (2021)
Why Test for Proportional Hazards?
Mats J. Stensrud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome
Patrick Royston et al.
TRIALS (2020)
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J. Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Managing Stable Ischemic Heart Disease
Elliott M. Antman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combined test versus logrank/Cox test in 50 randomised trials
Patrick Royston et al.
TRIALS (2019)
Modestly weighted logrank tests
Dominic Magirr et al.
STATISTICS IN MEDICINE (2019)
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
G. W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials JACC Review Topic of the Week
John Gregson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Statistical power to detect violation of the proportional hazards assumption when using the Cox regression model
Peter C. Austin
JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION (2018)
Relative rates not relative risks: addressing a widespread misinterpretation of hazard ratios
Rinku Sutradhar et al.
ANNALS OF EPIDEMIOLOGY (2018)
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
Stuart J. Head et al.
LANCET (2018)
Patient and physician preferences for attributes of coronary revascularization
Carlos Alberto da Silva Magliano et al.
PATIENT PREFERENCE AND ADHERENCE (2018)
Survival analysis: Part I - analysis time-to-event
Junyong In et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2018)
Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results
Dae Hyun Kim et al.
JAMA CARDIOLOGY (2017)
Estimation of treatment effects in weighted log-rank tests
Ray S. Lin et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2017)
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
G. B. John Mancini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Use of composite endpoints in clinical trials
Abdul J. Sankoh et al.
STATISTICS IN MEDICINE (2014)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Patient Preferences for Coronary Artery Bypass Graft Surgery or Percutaneous Intervention in Multivessel Coronary Artery Disease
Ryan Kipp et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)
Incidence of diabetes among postmenopausal breast cancer survivors
L. L. Lipscombe et al.
DIABETOLOGIA (2013)
Statistical considerations when using a composite endpoint for comparing treatment groups
Guadalupe Gomez et al.
STATISTICS IN MEDICINE (2013)
Strategies for Multivessel Revascularization in Patients with Diabetes
Michael E. Farkouh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Misspecification of Cox regression models with composite endpoints
Longyang Wu et al.
STATISTICS IN MEDICINE (2012)
Comparison of procedures to assess non-linear and time-varying effects in multivariable models for survival data
Anika Buchholz et al.
BIOMETRICAL JOURNAL (2011)
The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
Patrick Royston et al.
STATISTICS IN MEDICINE (2011)
Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
Carine A. Bellera et al.
BMC MEDICAL RESEARCH METHODOLOGY (2010)
Analyzing survival curves at a fixed point in time
John P. Klein et al.
STATISTICS IN MEDICINE (2007)
Joint estimation of time-dependent and non-linear effects of continuous covariates on survival
Michal Abrahamowicz et al.
STATISTICS IN MEDICINE (2007)
分享论文
